Covance ist jetzt Labcorp Drug Development

Wir sind ein globales Unternehmen, das für Millionen innovativ ist – gemeinsam, um Ihnen weiterhin fortschrittlichere medizinische Durchbrüche zu ermöglichen.

Mehr erfahren

Photo of a doctor with an elderly patient

We’re here to help find the answers that move you forward

Fast Track Discovery Program

Expedite your preclinical oncology discovery studies by leveraging our fast track program protocol yielding dependable data, supported by our scientific experts.


Save 4 weeks thanks to quick start dates and expedited report delivery

Collaborate with scientific experts to move your program forward effectively

Make dependable decisions based on data-rich final reports

When it comes to access to oncology drugs, cancer patients can't wait. That's why making quick decisions about early candidates is vital to providing life-changing drugs faster.

Save 4 weeks on your screening, proof of concept or simple combination studies with our fast track program. Leverage our pre-determined battery of models and studies to experience accelerated timelines while relying on the same high quality scientific engagement and collaboration you have come to depend on from our highly trained team members.

Photo of a lab worker

Save 4 Weeks

Benefit from a comprehensive study design with set parameters, expedited initiation and a modified final report to reduce timelines by at least 4 weeks. Qualifying studies are guaranteed cell expansion start dates within 2 weeks of a signed SOW, while a modified, yet thorough final report is guaranteed 2 weeks after study termination reducing the standard study timeline.

Collaborate with Scientific Experts

Scientific insight before, during and upon delivery of the final report is a built-in benefit despite the quick turnaround time. Our high caliber, highly trained scientific development team will guide you through the execution process by leading scientific discussions and answering any question that will help move your program forward effectively and efficiently.

Make Dependable Decisions

In this case, time savings does not sacrifice quality. Depend on regular updates throughout study execution and a data-rich final report - just 2 weeks after the study concludes - that will contain all of the data, comments, endpoint analyses and graphics, you need to evaluate candidates with confidence.

Program Qualifiers

To reach top speed efficiently, the following criteria is required to be met to qualify for our fast track program:

  • Compound must be in-house ready for near immediate shipment.
    • If material needs to be pathogen tested, the scientific development team will provide guidance as to where samples must be sent.
  • Select from our pre-approved subcutaneous or orthotopic mammary fat pad models.
  • Study design cannot exceed 80 mice on study.
    • Maximum treatment window– 21 day
    • Total in-life duration– 35 days
  • Only limited survival and terminal sampling are allowed.
  • No imaging or radiation treatment allowed.
  • Bioanalysis may be offered as a separate agreement.
  • Significant changes to the protocol may result in change fees and timeline delays.

Unterhalten wir uns